Podcast: What you need to know about apomorphine pump treatment for Parkinson’s disease


Author: Sophie ParrottPublished: 20 April 2023

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A composite image showing a photo of Bob and Liz Taylor next to a photo of Dr Tove Henriksen

In this episode of our multi-award-winning podcast, a neurologist and a couple impacted by Parkinson’s meet to discuss apomorphine pump treatment and its potential impact for people living with the condition

“I felt numb.” These are the words UK-based Bob Taylor uses to describe the moment he received his Parkinson’s diagnosis back in the late 1990s. “I didn’t hear much of the conversation afterwards – it came as a bit of a shock.”

More than 20 years on, Bob and his wife, Liz Taylor, have been on a “rollercoaster of a journey” together. During this time, they have explored several different treatment options to help manage his symptoms, including deep brain stimulation.

Among the options they have tried is an apomorphine pump – a small device that provides doses of a type of liquid dopamine agonist, which is primarily used to treat people in more ‘advanced’ stages of the condition.

“When Bob first started to use the apomorphine pump, it was primarily because he had been taking so much medication [to help manage his symptoms],” explains Liz, who has supported Bob as a caregiver throughout his experience. “He was having such severe ‘on-off’ periods that it was really difficult to get a good quality of life and to actually achieve anything on a daily basis. Using the pump has enabled Bob to carry on without these violent ‘on-off’ periods.”

An expert perspective

In this episode of the Parkinson’s Life podcast, Bob and Liz are joined by neurologist Dr Tove Henriksen – who shares her professional perspective on this kind of  treatment.

Based at the Bispebjerg Hospital in Copenhagen, Denmark, Tove has been helping to treat people with the condition for around 30 years.

She explains that one advantage of an apomorphine pump is its potential to “diminish the motor fluctuations of the ‘on-off’ phenomena that you may have experienced. So, in that way, you can reduce the number of pills and the number of medications that will be necessary throughout the day.”

Tove encourages those considering this treatment option to consult others who have experience with the  pump: “I can only say what it entails when you look at it from the outside, but the [people] who are using it – they can tell the whole story.”

To hear more from Bob, Liz and Tove, tune into the latest episode of the multi-award-winning Parkinson’s Life podcast.

This episode was sponsored by Convatec, and Tove Henriksen has been paid by Convatec to provide information for this podcast. The information in this podcast is given for information purposes only and is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Opinions expressed within this podcast are those of the individuals and not necessarily representative of Convatec.

Read more:

Podcast: Freezing, moving and cueing – understanding gait and Parkinson’s disease

Podcast: Getting involved in Parkinson’s disease research

Go Back

Share this story


Related articles

Dr Tove Henriksen wearing a blue scarf posing in front of a grey background.

sponsored article

PD in Practice

What you need to know about apomorphine pump treatment for Parkinson’s disease

Dr Tove Henriksen on how the treatment may support people with the conditio

News image


Study proves the effectiveness of Parkinson’s drug apomorphine

Results from the 12-week TOLEDO study – which tested the effectiveness of

A composite image of Martina Mancini and David Little.


Podcast: Freezing, moving and cueing – understanding gait and Parkinson’s disease

Two guests on the symptom’s “profound” impact